The Valley Desk

ArticleArthritis & rheumatology (Hoboken, N.J.)Published

Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-Based Target Trial Emulation

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Arthritis & rheumatology (Hoboken, N.J.)
Published
Subject terms
Humans; Cardiovascular Diseases; Myocardial Infarction; Lupus Erythematosus, Systemic; Diabetes Mellitus, Type 2; Treatment Outcome; Hospitalization; Proportional Hazards Models; Comorbidity; Primary Prevention; Adult; Aged
PubMed ID
39431397
Added to directory
Source checked

Report a correction or request removal